{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:16:48Z","timestamp":1784855808796,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000959","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T22:08:41Z","timestamp":1297202921000},"page":"e959","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Levofloxacin Cures Experimental Pneumonic Plague in African Green Monkeys"],"prefix":"10.1371","volume":"5","author":[{"given":"Robert Colby","family":"Layton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor L.","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"<italic>Yersinia pestis<\/italic> - etiologic agent of plague.","volume":"10","author":"RD Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"ref2","first-page":"159","article-title":"Pneumonic plague.","volume":"18","author":"G Krishna","year":"2003","journal-title":"Semin Respir Infect"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a bioweapon. Medical management and prevention.","volume":"283","author":"TV Inglesby","year":"2000","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(99)05163-6","article-title":"Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar.","volume":"355","author":"M Ratsitorahina","year":"2000","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3201\/eid1203.051051","article-title":"Pneumonic plague cluster, Uganda, 2004.","volume":"12","author":"EM Begier","year":"2006","journal-title":"Emerging Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague.","volume":"40","author":"JL Kool","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03130170165036","article-title":"Pneumonic plague in an unteated plague-vaccinated individual.","volume":"202","author":"RJ Cohen","year":"1967","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4269\/ajtmh.1994.51.109","article-title":"Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona.","volume":"51","author":"JM Doll","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jama.1984.03340310043018","article-title":"Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, Calif.","volume":"251","author":"SB Werner","year":"1984","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/infdis\/104.1.78","article-title":"Pneumonic plague in mice: gross and histopathology in untreated and passively immunized animals.","volume":"104","author":"PN Smith","year":"1959","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1073\/pnas.0506840102","article-title":"Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity.","volume":"102","author":"WW Lathem","year":"2005","journal-title":"Proc Nat Acad Sci US"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.00403-06","article-title":"Delayed inflammatory response to primary pneumonic plage occurs in both outbred and inbread mice.","volume":"75","author":"SS Bubeck","year":"2007","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.micinf.2008.11.009","article-title":"Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92.","volume":"11","author":"SL Agar","year":"2009","journal-title":"Microbes Infect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1073\/pnas.97.16.8778","article-title":"Molecular and cell biology aspects of plague.","volume":"97","author":"GR Cornelis","year":"2000","journal-title":"Proc Nat Acad Sci US"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.4049\/jimmunol.175.10.6750","article-title":"Early Interaction of Yersinia pestis with APCs in the Lung.","volume":"175","author":"CM Bosio","year":"2005","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1089\/dna.2006.25.608","article-title":"Expression profiling of Yersinia pestis during mouse pulmonary infection.","volume":"25","author":"JN Lawson","year":"2006","journal-title":"DNA Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/AAC.42.3.675","article-title":"Antibiotic treatment of experimental pneumonic plague in mice.","volume":"42","author":"WR Byrne","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","first-page":"99","article-title":"Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis.","volume":"53","author":"MJ Finegold","year":"1968","journal-title":"Am J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/infdis\/129.Supplement_1.S85","article-title":"Live, attenuated <italic>Yersinia pestis<\/italic> vaccine: virulent in nonhuman primates, harmless to guinea pigs.","volume":"129","author":"KF Meyer","year":"1974","journal-title":"J Infect Dis"},{"key":"ref20","first-page":"156","article-title":"Pathology of experimental pneumonic plague produced by fraction-1-positive and fraction-1-negative <italic>Yersinia pestis<\/italic> in African green monkeys.","volume":"120","author":"KJ Davis","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"ref21","first-page":"107","article-title":"Plague.","author":"JJ Adamovicz","year":"2006"},{"key":"ref22","article-title":"Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.","author":"RC Layton","year":"2010","journal-title":"J Med Primatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3201\/eid0910.030231","article-title":"Syndromic surveillance and bioterrorism-related epidemics.","volume":"9","author":"JW Buehler","year":"2003","journal-title":"Emerging Infectious Diseases"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268809990689","article-title":"Using syndromic surveillance systems to detect pneumonic plague.","volume":"138","author":"SM Babin","year":"2010","journal-title":"Epidemiol Infect"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010406","article-title":"Syndromic surveillance for local outbreaks of lower-respiratory infections: Would it work?","volume":"5","author":"C Van den Wijngaard","year":"2010","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/AAC.49.12.5099-5106.2005","article-title":"Identification of effective antimicrobial regimens for use in humans for the therapy of <italic>Bacillus anthracis<\/italic> infections and postexposure prophylaxis.","volume":"49","author":"MR Deziel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1128\/AAC.00090-06","article-title":"Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.","volume":"50","author":"ML Kao","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003495-200868040-00011","article-title":"Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infections.","volume":"68","author":"VR Anderson","year":"2008","journal-title":"Drugs"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/eri.10.35","article-title":"Levofloxacin in the treatment of community-acquired pneumonia.","volume":"8","author":"AM Noreddin","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref30","first-page":"706","article-title":"Vest and tethering system to accomodate catheters and a temperature monitor for nonhuman primates.","volume":"30","author":"JM Bryant","year":"1980","journal-title":"Lab Anim Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2003.07.001","article-title":"The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates.","volume":"49","author":"JM Hartings","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/08958370802105413","article-title":"Lung deposition of droplet aerosols in monkeys.","volume":"20","author":"Y-S Cheng","year":"2008","journal-title":"Inhalation Toxicology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/IAI.01296-09","article-title":"Milestones in progression of primary pneumonic plague in cynomolgus macaques.","volume":"78","author":"FT Koster","year":"2010","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/520547","article-title":"Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.","volume":"196","author":"HS Heine","year":"2007","journal-title":"J Infect Dis"},{"key":"ref35","first-page":"68","article-title":"Clinical and pathologic features of cynomolgus macaques (<italic>Macaca fascicularis<\/italic>) infected with aerosolized <italic>Yersinia pestis<\/italic>.","volume":"58","author":"R Van Andel","year":"2008","journal-title":"Comparative Medicine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/IAI.00699-08","article-title":"Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.","volume":"76","author":"CA Cornelius","year":"2008","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/381545","article-title":"Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in New Mexico, 1985\u20131999.","volume":"38","author":"LL Boulanger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/500137","article-title":"Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.","volume":"42","author":"W Mwengee","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dkg484","article-title":"Antibiotic susceptibilities of 94 isolates of <italic>Yersinia pestis<\/italic> to 24 antimicrobial agents.","volume":"52","author":"E Hernandez","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref40","first-page":"1315","author":"RJ Thomas","year":"2009"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.","volume":"103","author":"NJ Vietri","year":"2006","journal-title":"Proc Nat Acad Sci US"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.00306-06","article-title":"Resistance of Yersinia pestis to Antimicrobial Agents.","volume":"50","author":"M Galimand","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00204-009-0509-9","article-title":"A comparative analysis of chromosomal aberrations in cultured human lymphocytes due to fluoroquinolone drugs at different expression periods.","volume":"84","author":"M Anupama","year":"2010","journal-title":"Arch Toxicol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","article-title":"Safety profile of the fluoroquinolones: focus on levofloxacin.","volume":"33","author":"HH Liu","year":"2010","journal-title":"Drug Saf"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/AAC.00073-07","article-title":"Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.","volume":"51","author":"A Louie","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.49.12.5107-5111.2005","article-title":"In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.","volume":"49","author":"D Hutschala","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1128\/AAC.47.8.2450-2457.2003","article-title":"Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azrithromycin in health adults.","volume":"47","author":"KA Rodvold","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:59:46Z","timestamp":1588971586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000959"}},"subtitle":[],"editor":[{"given":"Didier","family":"Raoult","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000959","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,8]]}}}